Abstract
Human cryptococcosis, an infection caused by Cryptoccocus spp., was classified by the WHO as a high priority for the development of therapies. Cryptococcosis has an estimated global annual incidence of 1 million cases, being an invasive fungal infection (IFI) with the lowest percentages of investment in research among neglected diseases. The genomic plasticity of Cryptococcus spp. associa…